MétaCan
Menu
← Retour à la cohorte
Enregistrement W4417009769 · doi:10.1182/blood-2025-2772

Reassessing bone marrow staging practices in limited-stage follicular lymphoma in the PET era

2025· article· en· W4417009769 sur OpenAlexaffabout
Marissa Solow, Carolyn Owen, Colin C. Stewart, Jeffrey Cao, Alex Balogh, Sarah Perry, Mona Shafey, Lesley Street, Douglas A. Stewart, Robert Puckrin

Notice bibliographique

RevueBlood · 2025
Typearticle
Langueen
DomaineMedicine
ThématiqueLymphoma Diagnosis and Treatment
Établissements canadiensUniversity of AlbertaUniversity of Calgary
Organismes subventionnairesnon disponible
Mots-clésFollicular lymphomaPositron emission tomographyBone marrowBiopsyLymphomaRetrospective cohort studyFine-needle aspiration

Résumé

récupéré en direct d'OpenAlex

Abstract Introduction: Bone marrow (BM) involvement is present in approximately 50% of patients with follicular lymphoma (FL) and is associated with an inferior prognosis. Although BM aspiration and biopsy (A&B) have traditionally been recommended as staging investigations for FL, emerging evidence indicates that routine BM A&B at diagnosis or follow-up rarely affects clinical management and may be safely omitted for most patients with advanced-stage disease. Nevertheless, international guidelines continue to recommend BM sampling alongside F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) imaging to confirm cases of suspected limited-stage FL, particularly when curative-intent treatment with radiation therapy (RT) is being considered. However, the diagnostic utility of routine BM A&B in patients with suspected limited-stage FL as defined by PET remains uncertain. Methods: This retrospective population-based study included consecutive patients with PET-defined limited-stage FL who underwent BM sampling in Alberta, Canada between 2017 and 2023. Provincial guidelines recommended BM A&B for confirming limited-stage disease or investigating unexplained cytopenias, although this decision was ultimately at the discretion of the treating physician. The primary objective of this study was to determine the diagnostic utility of BM A&B in the study population. Results: Among 1,209 patients diagnosed with FL during the study period, 295 (24%) presented with radiographically-defined limited-stage disease by PET (n=114) or CT (n=181). A staging BM A&B was performed in only 84 (28%) of suspected limited-stage cases, including 50/113 (44%) patients who received RT, largely reflecting variation in practice between physicians. A total of 60 patients with PET-defined limited-stage FL underwent BM aspiration (n=59) and/or biopsy (n=60) and were included in this study. The median age of these patients was 65 years (range 31-82). The PET-defined Lugano disease stage was I in 31 (52%), IE in 5 (8%), and II in 24 (40%) patients. Treatment strategies included 24-30 Gray of RT (n=44), active surveillance (n=11), chemoimmunotherapy (n=4), or rituximab monotherapy (n=1). The results of the BM A&B were negative for FL in 56 (93%) cases, including 3 (5%) patients who exhibited an unrelated low-level B-cell clone (e.g. monoclonal B-cell lymphocytosis) detected by flow cytometry of the BM aspirate. Only 4 (6%) patients had FL detected on BM aspirate (n=1), biopsy (n=1), or both (n=2), despite having no evidence of marrow involvement on PET. Notably, none of these 4 patients displayed abnormalities in routine bloodwork, including CBC, LDH, β2-microglobulin, or SPEP, other than a single patient with a monoclonal protein related to a plasma cell neoplasm. The calculated number of patients required to undergo BM A&B to identify one case of marrow involvement with FL was 15. Importantly, the positive findings from the BM A&B did not alter the clinical management of any of the 4 patients; specifically, 2 patients received RT despite their low-level BM involvement, while 2 patients were not planned to receive RT from the outset due to a concurrent plasma cell neoplasm or disease extending beyond a single radiation field. Conclusions: Despite provincial and international guidelines recommending staging BM A&B to confirm suspected cases of limited-stage FL, the findings of this study indicate that BM sampling is widely perceived by physicians to have limited value and is frequently omitted in routine clinical practice, including in over 50% of patients treated with curative-intent RT. Additionally, among the 60 patients in this cohort with PET-defined limited-stage disease, BM A&B identified unexpected marrow involvement in only 1 in 15 (6%) patients and did not lead to a change in clinical management for any individual. These results call into question the utility of routine BM A&B in PET-defined limited-stage FL, particularly given the associated healthcare costs, resource demands, and discomfort of this invasive procedure. These findings may assist patients and physicians in engaging in informed discussions regarding the utility of BM sampling in this setting.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,003
score de la tête « metaresearch » (Gemma)0,011
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,111
Score d'incertitude au seuil0,220

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0030,011
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0010,001
Études des sciences et des technologies0,0000,001
Communication savante0,0010,001
Science ouverte0,0010,001
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0010,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,022
Tête enseignante GPT0,307
Écart entre enseignants0,285 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2025
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revueBlood→Même sujetLymphoma Diagnosis and Treatment→Travaux en français237 207→